Tribal Opioid Response

The Tribal Opioid Response program is administered by the U.S. Department of Health and Human Services through the Substance Abuse and Mental Health Services Administration. This federal initiative is part of a broader national effort to combat the opioid crisis, particularly in underserved and disproportionately impacted communities. SAMHSA has a long-standing role in advancing behavioral health programs across the United States, including prevention, treatment, and recovery services for substance use disorders. This specific program is designed to address the unique challenges faced by American Indian and Alaska Native populations, where opioid misuse and overdose rates have created significant public health concerns. The primary purpose of the Tribal Opioid Response program is to expand access to evidence-based interventions for opioid use disorder within Tribal communities. The program emphasizes the use of FDA-approved medications for opioid use disorder, alongside comprehensive prevention strategies and recovery support services. In addition to opioids, the funding also supports activities addressing stimulant misuse, including substances such as cocaine and methamphetamine. This dual focus reflects an understanding of overlapping substance use trends and the need for integrated approaches to behavioral health treatment. Funding provided through this program is intended to support a continuum of care that includes prevention, treatment, and long-term recovery services. Allowable uses of funds include expanding clinical treatment capacity, implementing culturally appropriate prevention programs, supporting recovery infrastructure, and addressing co-occurring mental health conditions. While specific funding restrictions are not detailed in the forecast, federal grant programs of this nature typically require adherence to strict reporting, compliance, and allowable cost guidelines. Notably, this opportunity does not require cost sharing or matching funds, reducing financial barriers for eligible applicants. Eligibility for the Tribal Opioid Response program is limited to federally recognized American Indian or Alaska Native Tribes and Tribal organizations, as defined in federal statute. Applicants may apply individually or as part of a consortium, and partnerships with Urban Indian Organizations are permitted. This inclusive eligibility structure is designed to encourage collaboration and regional coordination while ensuring that funding directly benefits Tribal populations. Entities must meet federal recognition criteria and align their proposed activities with the program’s goals. The application process for this opportunity will be administered through Grants.gov once the funding opportunity is officially posted. As this is currently a forecasted opportunity, specific submission steps, required application components, and evaluation criteria have not yet been published. However, applicants can expect standard federal grant requirements, including detailed project narratives, budget justifications, and organizational capacity documentation. Evaluation criteria will likely prioritize demonstrated need, program design, cultural competency, and the ability to achieve measurable outcomes. Key timeline elements indicate that the opportunity is expected to be posted on May 29, 2026, following a forecast release earlier in March 2026. While application deadlines and award dates have not yet been specified, the program is aligned with fiscal year 2026 funding cycles. Interested applicants are encouraged to monitor Grants.gov for updates and prepare in advance by ensuring registration compliance and readiness of required documentation. For additional information, SAMHSA has provided a contact point for inquiries, including both a phone number and email address for program-related questions.